Table 4.
TCGA progression-free interval (PFI) tasks
| TCGA PFI tasks | |||||
|---|---|---|---|---|---|
| Project | Disease | Label | Label type | Group | Samples |
| CESC | cervical squamous cell carcinoma | PFI | survival | train | 304 |
| COAD | colon adenocarcinoma | PFI | survival | train | 455 |
| ESCA | esophageal carcinoma | PFI | survival | train | 184 |
| KIRP | kidney papillary cell carcinoma | PFI | survival | train | 288 |
| LUAD | lung adenocarcinoma | PFI | survival | train | 507 |
| OV | ovarian cancer | PFI | survival | train | 420 |
| PAAD | pancreatic adenocarcinoma | PFI | survival | train | 178 |
| SARC | sarcoma | PFI | survival | train | 259 |
| STAD | stomach adenocarcinoma | PFI | survival | train | 411 |
| UCEC | uterine corpus endometrial carcinoma | PFI | survival | train | 540 |
| HNSC | head-neck squamous cell carcinoma | PFI | survival | validate | 501 |
| BLCA | bladder urothelial carcinoma | PFI | survival | test | 408 |
| LUSC | lung squamous cell carcinoma | PFI | survival | test | 496 |
The 13 progression-free surivival tasks derived from TCGA used to train supervised models and validate the unsupervised embeddings. The project names correspond to those in Fig. 2